Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri

Neurogenetics

Volumn 13, Issue 1, 2012, Pages 1-7

  Van Den Munckhof, Pepijn ^a   Christiaans, Imke ^a   Kenter, Susan B ^a   Baas, Frank ^a   Hulsebos, Theo J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Falx meningioma; Multiple meningiomas; Schwannomatosis; SMARCB1 mutation

Indexed keywords

NEUROFIBROMATOSIS TYPE 2 PROTEIN; PROTEIN; SMARCB1 PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MICROSATELLITE DNA; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; EXON; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; MALE; MENINGIOMA; MISSENSE MUTATION; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WILD TYPE; AGED; DURA MATER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEDIGREE;

ADULT; AGED; BASE SEQUENCE; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; DURA MATER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURILEMMOMA; PEDIGREE; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84861308497     PISSN: 13646745     EISSN: 13646753     Source Type: Journal    
DOI: 10.1007/s10048-011-0300-y     Document Type: Article

References (14)

1. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805-810 (Pubitemid 46564417)
2. Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358-366
3. Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, McCann E, Trump D, Prescott T, Evans DG (2008) Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet 45:332-339 (Pubitemid 351839473)
4. Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L (2008) Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.HumMutat 29:227-231 (Pubitemid 351240594)
5. Rousseau G, Noguchi T, Bourdon V, Sobol H, Olschwang S (2011) SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. BMC Neurol 11:9
6. Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG (2010) Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29:6216-6221
7. Louis DN, Ramesh V, Gusella JF (1995) Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5:163-172
8. Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ (1994) Analysis of mutations in the SCH gene in schwannomas. Genes Chromosomes Cancer 11:7-14 (Pubitemid 24273968)
9. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins VP, Dumanski JP, Rouleau GA (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180-184 (Pubitemid 24188600)
10. Bacci C, Sestini R, Provenzano A, Paganini I, Mancini I, Porfirio B, Vivarelli R, Genuardi M, Papi L (2010) Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics 11:73-80
11. Hadfield KD, Smith MJ, Trump D, Newman WG, Evans DG (2010) SMARCB1 mutations are not a common cause of multiple meningiomas. J Med Genet 47:567-568
12. Christiaans I, Kenter SB, Brink HC, van Os TA, Baas F, van den Munckhof P, Kidd AM, Hulsebos TJ (2011) Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J Med Genet 48:93-97
13. Chung SB, Kim CY, Park CK, Kim DG, Jung HW (2007) Falx meningiomas: surgical results and lessons learned from 68 cases. J Korean Neurosurg Soc 42:276-280 (Pubitemid 350107661)
14. Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, Berger MS, Parsa AT (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117:1272-1278